The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study
Open accessAbstract
Objectives: Fluoroquinolone-associated tendon ruptures are a recognised complication, but other severe collagen-associated adverse events may also be possible. Our objectives were to confirm the association of fluoroquinolones and tendon rupture, to clarify the potential association of fluoroquinolones and retinal detachment, and to test for a potentially lethal association between fluoroquinolones and aortic aneurysms. Setting: Population-based longitudinal cohort study in Ontario, Canada. Participants: Older adults turning 65 years between April 1 1997 and March 31 2012 were followed until primary outcome, death, or end of follow-up (March 31 2014). Fluoroquinolone prescriptions were measured as a time-varying covariate, with patients considered at risk during and for 30 days following a treatment course. Primary outcome measures: Severe collagen-associated adverse events defined as tendon ruptures, retinal detachments and aortic aneurysms diagnosed in hospital and emergency departments. Results: Among the 1 744 360 eligible patients, 657 950 (38%) received at least one fluoroquinolone during follow-up, amounting to 22 380 515 days of treatment. The patients experienced 37 338 (2.1%) tendon ruptures, 3246 (0.2%) retinal detachments, and 18 391 (1.1%) aortic aneurysms. Severe collagen-associated adverse events were more common during fluoroquinolone treatment than control periods, including tendon ruptures (0.82 vs 0.26/100-person years, p<0.001), retinal detachments (0.03 vs 0.02/100-person-years, p=0.003) and aortic aneurysms (0.35 vs 0.13/100-person-years, p<0.001). Current fluoroquinolones were associated with an increased hazard of tendon rupture (HR 3.13, 95% CI 2.98 to 3.28; adjusted HR 2.40, 95% CI 2.24 to 2.57) and an increased hazard of aortic aneurysms (HR 2.72, 95% CI 2.53 to 2.93; adjusted HR2.24, 95% CI 2.02 to 2.49) that were substantially greater in magnitude than the association of these outcomes with amoxicillin. The hazard of retinal detachment was marginal (HR 1.28, 95% CI 0.99 to 1.65; adjusted HR 1.47, 95% CI 1.08 to 2.00) and not greater in magnitude than that observed with amoxicillin. Conclusions: Fluoroquinolones are associated with subsequent tendon ruptures and may also contribute to aortic aneurysms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Outpatient gatifloxacin therapy and dysglycemia in older adults.
Park-Wyllie, L. Y., Juurlink, D. N., Kopp, A., Shah, B. R., Stukel, T. A., Stumpo, C., Dresser, L., Low, D. E., & Mamdani, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055191 · Cited by 367
Cited by
Wanhainen, A., Van Herzeele, I., Bastos Goncalves, F., Bellmunt Montoya, S., Berard, X., Boyle, J. R., D’Oria, M., Prendes, C. F., Karkos, C. D., Kazimierczak, A., et al. (2024) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2023.11.002 · Cited by 1,207
The Continuing Threat of Methicillin-Resistant Staphylococcus aureus
Gajdács, M. (2019) · Antibiotics · doi:10.3390/antibiotics8020052 · Cited by 318
Megraud, F., Bruyndonckx, R., Coenen, S., Wittkop, L., Huang, T.-D., Hoebeke, M., Bénéjat, L., Lehours, P., Goossens, H., & Glupczynski, Y. (2021) · Gut · doi:10.1136/gutjnl-2021-324032 · Cited by 291
Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study
Pasternak, B., Inghammar, M., & Svanström, H. (2018) · BMJ · doi:10.1136/bmj.k678 · Cited by 255
Extracellular matrix, regional heterogeneity of the aorta, and aortic aneurysm
Jana, S., Hu, M., Shen, M., & Kassiri, Z. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0286-3 · Cited by 226
Metadata
- Authors
- Daneman, N., Lu, H., & Redelmeier, D. A.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2015-11
- Volume
- 5
- Issue
- 11
- Pages
- e010077
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2205625699
- Cited by
- 225
- References
- 1
- FWCI
- 21.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study. https://app.cochat.ai/papers/10.1136/bmjopen-2015-010077
- The paper
- Daneman, N., Lu, H., & Redelmeier, D. A. (2015). Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study. BMJ Open. https://doi.org/10.1136/bmjopen-2015-010077
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.